| A consensus on the diagnosis and treatment of acromegaly comorbidities: an update A Giustina, A Barkan, A Beckers, N Biermasz, BMK Biller, C Boguszewski, ... The Journal of Clinical Endocrinology & Metabolism 105 (4), e937-e946, 2020 | 279 | 2020 |
| A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR® (long‐acting repeatable octreotide) in the primary therapy of … M Mercado, F Borges, H Bouterfa, TC Chang, A Chervin, AJ Farrall, ... Clinical endocrinology 66 (6), 859-868, 2007 | 279 | 2007 |
| Multidisciplinary management of acromegaly: a consensus A Giustina, G Barkhoudarian, A Beckers, A Ben-Shlomo, N Biermasz, ... Reviews in Endocrine and Metabolic Disorders 21, 667-678, 2020 | 236 | 2020 |
| Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic M Mercado, B Gonzalez, G Vargas, C Ramirez, ALE de los Monteros, ... The Journal of Clinical Endocrinology & Metabolism 99 (12), 4438-4446, 2014 | 213 | 2014 |
| Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial S Melmed, V Popovic, M Bidlingmaier, M Mercado, AJ van der Lely, ... The Journal of Clinical Endocrinology & Metabolism 100 (4), 1699-1708, 2015 | 191 | 2015 |
| Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study D Iacovazzo, R Caswell, B Bunce, S Jose, B Yuan, ... Acta neuropathologica communications 4, 1-12, 2016 | 118 | 2016 |
| Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in nonfunctioning pituitary adenomas: a high throughput TMA, immunohistochemical study C Ramírez, S Cheng, G Vargas, SL Asa, S Ezzat, B Gonzalez, L Cabrera, ... The Journal of Clinical Endocrinology 97 (5), 1745-1751, 2012 | 114 | 2012 |
| Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. Modeling analysis and clinical … JD Veldhuis, ML Johnson, LM Faunt, M Mercado, G Baumann The Journal of clinical investigation 91 (2), 629-641, 1993 | 114 | 1993 |
| The Mexican Acromegaly Registry: clinical and biochemical characteristics at diagnosis and therapeutic outcomes LA Portocarrero-Ortiz, A Vergara-Lopez, M Vidrio-Velazquez, ... The Journal of Clinical Endocrinology & Metabolism 101 (11), 3997-4004, 2016 | 100 | 2016 |
| Distribution of growth hormone receptor messenger ribonucleic acid containing and lacking exon 3 in human tissues M Mercado, N DaVila, JF McLeod, G Baumann The Journal of Clinical Endocrinology & Metabolism 78 (3), 731-735, 1994 | 99 | 1994 |
| Low plasma growth hormone binding protein in IDDM M Mercado, ME Molitch, G Baumann Diabetes 41 (5), 605-609, 1992 | 93 | 1992 |
| A high-throughput proteomic approach provides distinct signatures for thyroid cancer behavior S Cheng, S Serra, M Mercado, S Ezzat, SL Asa Clinical Cancer Research 17 (8), 2385-2394, 2011 | 88 | 2011 |
| Clinical and biochemical characteristics of acromegalic patients with different abnormalities in glucose metabolism AL Espinosa-de-los-Monteros, B González, G Vargas, E Sosa, M Mercado Pituitary 14, 231-235, 2011 | 76 | 2011 |
| Treatment of hyperthyroidism with a combination of methimazole and cholestyramine M Mercado, V Mendoza-Zubieta, R Bautista-Osorio, ... The Journal of Clinical Endocrinology & Metabolism 81 (9), 3191-3193, 1996 | 76 | 1996 |
| Multifactorial control of the elimination kinetics of unbound (free) growth hormone (GH) in the human: regulation by age, adiposity, renal function, and steady state … F Schaefer, G Baumann, D Haffner, LM Faunt, ML Johnson, M Mercado, ... The Journal of Clinical Endocrinology & Metabolism 81 (1), 22-31, 1996 | 75 | 1996 |
| The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome JL Tapia, R Ramírez, J Cifuentes, J Fabres, ME Hübner, A Bancalari, ... The Journal of pediatrics 132 (1), 48-52, 1998 | 74 | 1998 |
| Clinical characteristics and treatment outcome of 485 patients with nonfunctioning pituitary macroadenomas G Vargas, B Gonzalez, C Ramirez, A Ferreira, E Espinosa, V Mendoza, ... International journal of endocrinology 2015, 2015 | 73 | 2015 |
| Clinically non-functioning pituitary adenomas: Pathogenic, diagnostic and therapeutic aspects M Mercado, V Melgar, L Salame, D Cuenca Endocrinologia, diabetes y nutricion 64 (7), 384-395, 2017 | 72 | 2017 |
| Clinical and biochemical impact of the d3 growth hormone receptor genotype in acromegaly M Mercado, B González, C Sandoval, Y Esquenazi, F Mier, G Vargas, ... The Journal of Clinical Endocrinology & Metabolism 93 (9), 3411-3415, 2008 | 70 | 2008 |
| Giant prolactinomas: are they really different from ordinary macroprolactinomas? E Espinosa, E Sosa, V Mendoza, C Ramírez, V Melgar, M Mercado Endocrine 52, 652-659, 2016 | 68 | 2016 |
